These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 16501248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.
    Cebrian A, Pharoah PD, Ahmed S, Smith PL, Luccarini C, Luben R, Redman K, Munday H, Easton DF, Dunning AM, Ponder BA.
    Cancer Res; 2006 Jan 15; 66(2):1225-33. PubMed ID: 16424062
    [Abstract] [Full Text] [Related]

  • 3. ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
    Milne RL, Ribas G, González-Neira A, Fagerholm R, Salas A, González E, Dopazo J, Nevanlinna H, Robledo M, Benítez J.
    Cancer Res; 2006 Oct 01; 66(19):9420-7. PubMed ID: 17018596
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM.
    Carcinogenesis; 2007 Aug 01; 28(8):1680-6. PubMed ID: 17449902
    [Abstract] [Full Text] [Related]

  • 6. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA, Stram DO, Cheng I, Giorgi EE, Pooler L, Penney K, Le Marchand L, Henderson BE, Freedman ML.
    Cancer Epidemiol Biomarkers Prev; 2006 May 01; 15(5):1021-5. PubMed ID: 16702386
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk.
    Han W, Kang SY, Kang D, Park SK, Lee JY, Kim H, Park AK, Noh DY.
    Oncol Rep; 2010 Mar 01; 23(3):763-9. PubMed ID: 20127018
    [Abstract] [Full Text] [Related]

  • 9. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.
    BMC Cancer; 2006 Sep 29; 6():230. PubMed ID: 17010193
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.
    Breast Cancer Res Treat; 2007 Jan 29; 101(1):73-81. PubMed ID: 16807674
    [Abstract] [Full Text] [Related]

  • 12. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S, Yaren A, Kursunluoglu R, Turgut G.
    Arch Med Res; 2007 Jul 29; 38(5):539-44. PubMed ID: 17560460
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
    Vega A, Salas A, Milne RL, Carracedo B, Ribas G, Ruibal A, de León AC, González-Hernández A, Benítez J, Carracedo A.
    Gynecol Oncol; 2009 Jan 29; 112(1):210-4. PubMed ID: 18950845
    [Abstract] [Full Text] [Related]

  • 15. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH, Ritchie MD, Jensrud SD, Motsinger AA, Alnaes GI, Lemmon G, Berg M, Geisler S, Moore JH, Lønning PE, Børresen-Dale AL, Kristensen VN.
    Pharmacogenet Genomics; 2007 Feb 29; 17(2):127-36. PubMed ID: 17301692
    [Abstract] [Full Text] [Related]

  • 16. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ.
    Cancer Epidemiol Biomarkers Prev; 2006 Jul 29; 15(7):1306-10. PubMed ID: 16835328
    [Abstract] [Full Text] [Related]

  • 17. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
    Loizidou MA, Michael T, Neuhausen SL, Newbold RF, Marcou Y, Kakouri E, Daniel M, Papadopoulos P, Malas S, Kyriacou K, Hadjisavvas A.
    Breast Cancer Res Treat; 2008 Dec 29; 112(3):575-9. PubMed ID: 18188695
    [Abstract] [Full Text] [Related]

  • 18. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
    Balasubramanian SP, Cross SS, Globe J, Cox A, Brown NJ, Reed MW.
    BMC Cancer; 2007 Jun 22; 7():107. PubMed ID: 17587451
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.
    Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, Zhang P, Sun P, Narod SA.
    Breast Cancer Res Treat; 2008 Dec 22; 112(3):585-93. PubMed ID: 18204969
    [Abstract] [Full Text] [Related]

  • 20. Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk.
    Vaclavicek A, Bermejo JL, Wappenschmidt B, Meindl A, Sutter C, Schmutzler RK, Kiechle M, Bugert P, Burwinkel B, Bartram CR, Hemminki K, Försti A.
    Breast Cancer Res Treat; 2007 Dec 22; 106(2):205-13. PubMed ID: 17268814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.